Abbott Laboratories is optimistic about the prospects for its neuromodulation technology. It cited the potential for quarterly sequential revenue growth increases over 2019 in neuromodulation and has doubled its R&D investment in the field in order to maximize the and expand upon its pair of neuromodulation products. Read More
